| Name | Title | Contact Details |
|---|
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
Polymedco Inc. is a Cortlandt Manor, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products.
Foxwall Emergency Medical Svc is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carl Ziess is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.